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A 73-year-old man with prostate cancer had undergone bone scin-
tigraphy with technetium-99 m hydroxymethylene diphosphonate
(99mTc-HMDP) to detect metastasis, and he was referred to us from
the urology department because of abnormal cardiac accumulation. In
general, 99mTc-HMDP scintigraphy showed no cardiac accumulation
(Fig. 1A). However, the patient exhibited signiﬁcant uptake in the
heart (Fig. 1B), especially in the anterior, septal, and inferior walls on
the short axis (Fig. 1C) and horizontal views (Fig. 1D). His family history
was unremarkable. He has been treated for hypertension and dyslipid-
emia for 20 years and did not have cardiac symptoms.
Transcatheter coronary angiography showed no signiﬁcant coronary
artery stenosis. Left ventricular endomyocardial biopsy revealed
hypertrophied cardiomyocytes with a disordered arrangement and
extracellular deposition of pale eosinophilic homogenous amorphous
materials on hematoxylin and eosin staining (Fig. 2A). The amorphous
materials stained positively with Congo red and were conﬁrmed to be
amyloidﬁbrils (Fig. 2B). The patientwas diagnosedwith cardiac amyloid-
osis. Chemotherapy for prostate cancer was initiated, and we carefully
followed the patient for early detection of heart failure-related events.
In the present case, cardiac accumulation was incidentally detected
with bone scintigraphy, leading to the diagnosis of cardiac amyloidosis.
The usefulness of bone scintigraphy has been reported in some litera-
tures [1–6]. Whereas, the differential diagnosis of cardiac accumulation
by bone scintigraphy includes previous myocardial infarction, hyper-
parathyroidism, and benign myocardial uptake; the diagnostic sensitiv-
ity of this ﬁnding in cardiac amyloidosis is not sufﬁciently high to
warrant patient screening [7]. However, this case suggests detailed car-
diac examinations should be performed at least when cardiac abnormal
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Fig. 1. Bone scintigraphy with technetium-99 m hydroxymethylene diphosphonate shows no cardiac accumulation (A). However, signiﬁcant uptake can be observed in the heart (B), es-
pecially in the anterior, septal, and inferior walls on the short axis (C) and horizontal views (D).
Fig. 2. Left ventricular endomyocardial biopsy shows hypertrophied cardiomyocytes with a disordered arrangement and extracellular deposits of pale eosinophilic homogenous amor-
phous materials on hematoxylin and eosin staining (A). The amorphous materials stained positively with Congo red and were conﬁrmed to be amyloid ﬁbrils (B).
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